{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:45:37Z","timestamp":1791081937380,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Radiation Oncology"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.semradonc.2009.09.002","type":"journal-article","created":{"date-parts":[[2009,12,2]],"date-time":"2009-12-02T10:12:04Z","timestamp":1259748724000},"page":"67-78","source":"Crossref","is-referenced-by-count":111,"title":["Secondary Malignancies Across the Age Spectrum"],"prefix":"10.1016","volume":"20","author":[{"given":"Andrea K.","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa B.","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel S.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois B.","family":"Travis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semradonc.2009.09.002_bib1","series-title":"SEER Cancer Statistics Review, 1975-2004","author":"Ries","year":"2007"},{"key":"10.1016\/j.semradonc.2009.09.002_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jnci\/djj001","article-title":"Cancer survivorship\u2014genetic susceptibility and second primary cancers: Research strategies and recommendations","volume":"98","author":"Travis","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/jnci\/93.8.618","article-title":"Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study","volume":"93","author":"Neglia","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib4","series-title":"New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000","author":"Curtis","year":"2006"},{"key":"10.1016\/j.semradonc.2009.09.002_bib5","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.bjc.6602226","article-title":"Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain","volume":"91","author":"Jenkinson","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib6","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1200\/JCO.2008.21.1920","article-title":"Second neoplasms in survivors of childhood cancer: Findings from the Childhood Cancer Survivor Study cohort","volume":"27","author":"Meadows","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib7","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1200\/JCO.2001.19.13.3163","article-title":"Late mortality experience in five-year survivors of childhood and adolescent cancer: The Childhood Cancer Survivor Study","volume":"19","author":"Mertens","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib8","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1200\/JCO.2001.19.13.3173","article-title":"Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: A population-based study in the Nordic countries","volume":"19","author":"Moller","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib9","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/pbc.20028","article-title":"Long-term cause-specific mortality among five-year survivors of childhood cancer","volume":"42","author":"Cardous-Ubbink","year":"2004","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib10","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1056\/NEJM199111073251902","article-title":"Second neoplasms after acute lymphoblastic leukemia in childhood","volume":"325","author":"Neglia","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2009.09.002_bib11","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1182\/blood.V95.9.2770.009k16_2770_2775","article-title":"Secondary neoplasms subsequent to Berlin-Frankfurt-M\u00fcnster therapy of acute lymphoblastic leukemia in childhood: Significantly lower risk without cranial radiotherapy","volume":"95","author":"Loning","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2009.09.002_bib12","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1182\/blood.V99.12.4257","article-title":"Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983","volume":"99","author":"Bhatia","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2009.09.002_bib13","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1001\/jama.297.11.1207","article-title":"Cumulative incidence of secondary neoplasms as a first event after childhood acute lymphoblastic leukemia","volume":"297","author":"Hijiya","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.semradonc.2009.09.002_bib14","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/jnci\/djj411","article-title":"New primary neoplasms of the central nervous system in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study","volume":"98","author":"Neglia","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib15","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1200\/JCO.1998.16.12.3761","article-title":"Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital","volume":"16","author":"Walter","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0140-6736(98)11079-6","article-title":"High incidence of secondary brain tumours after radiotherapy and antimetabolites","volume":"354","author":"Relling","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2009.09.002_bib17","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1136\/bmj.304.6832.951","article-title":"Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer","volume":"304","author":"Hawkins","year":"1992","journal-title":"BMJ"},{"key":"10.1016\/j.semradonc.2009.09.002_bib18","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM199112123252402","article-title":"Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia","volume":"325","author":"Pui","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2009.09.002_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/blood-2002-11-3343","article-title":"Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: The University of Chicago series","volume":"102","author":"Smith","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2009.09.002_bib20","first-page":"1990","article-title":"Epipodophyllotoxin-related acute myeloid leukemia: A study of 35 cases","volume":"9","author":"Pui","year":"1995","journal-title":"Leukemia"},{"key":"10.1016\/j.semradonc.2009.09.002_bib21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1200\/JCO.1994.12.5.1063","article-title":"Leukemia risk following Hodgkin's disease: Relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage","volume":"12","author":"van Leeuwen","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/pbc.20380","article-title":"High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adults","volume":"45","author":"Le Deley","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib23","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.ejca.2006.05.034","article-title":"Role of radiotherapy and chemotherapy in the risk of secondary leukaemia after a solid tumour in childhood","volume":"42","author":"Haddy","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib24","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM198605083141901","article-title":"Prediction of familial predisposition to retinoblastoma","volume":"314","author":"Cavenee","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2009.09.002_bib25","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1200\/JCO.2005.05.054","article-title":"Risk of new cancers after radiotherapy in long-term survivors of retinoblastoma: An extended follow-up","volume":"23","author":"Kleinerman","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/jnci\/djh058","article-title":"Lifetime risks of common cancers among retinoblastoma survivors","volume":"96","author":"Fletcher","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib27","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/jnci\/djn394","article-title":"Risk of second malignancies in survivors of retinoblastoma: More than 40 years of follow-up","volume":"100","author":"Marees","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/jnci\/88.5.270","article-title":"Radiotherapy, alkylating agents, and risk of bone cancer after childhood cancer","volume":"88","author":"Hawkins","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib29","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1001\/jama.278.15.1262","article-title":"Cancer incidence after retinoblastoma: Radiation dose and sarcoma risk","volume":"278","author":"Wong","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.semradonc.2009.09.002_bib30","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1056\/NEJM198709033171002","article-title":"Bone sarcomas linked to radiotherapy and chemotherapy in children","volume":"317","author":"Tucker","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2009.09.002_bib31","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1200\/JCO.1999.17.6.1829","article-title":"Trilateral retinoblastoma: A meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma","volume":"17","author":"Kivela","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/jnci\/djk002","article-title":"Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma","volume":"99","author":"Kleinerman","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijrobp.2008.04.067","article-title":"Subsequent malignancies in children treated for Hodgkin's disease: Associations with gender and radiation dose","volume":"72","author":"Constine","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2009.09.002_bib34","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.1200\/JCO.2003.11.059","article-title":"High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: Report from the Late Effects Study Group","volume":"21","author":"Bhatia","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib35","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1200\/JCO.1996.14.5.1442","article-title":"Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries","volume":"14","author":"Sankila","year":"1996","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib36","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1182\/blood-2002-02-0634","article-title":"Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: Long-term risks and risk factors","volume":"100","author":"Ng","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2009.09.002_bib37","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2000.18.3.498","article-title":"Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment","volume":"18","author":"Swerdlow","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib38","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1200\/JCO.2000.18.7.1492","article-title":"Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence","volume":"18","author":"Green","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib39","doi-asserted-by":"crossref","first-page":"590","DOI":"10.7326\/0003-4819-141-8-200410190-00006","article-title":"Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study","volume":"141","author":"Kenney","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semradonc.2009.09.002_bib40","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1182\/blood-2004-09-3411","article-title":"Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: An international case-control study","volume":"105","author":"Curtis","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2009.09.002_bib41","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1600-0609.2005.00458.x","article-title":"Report from the Rockefeller Foundation Sponsored International Workshop on reducing mortality and improving quality of life in long-term survivors of Hodgkin's disease","volume":"66","author":"Mauch","year":"2005","journal-title":"Eur J Haematol Suppl"},{"key":"10.1016\/j.semradonc.2009.09.002_bib42","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","article-title":"Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease","volume":"290","author":"Travis","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.semradonc.2009.09.002_bib43","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/jnci\/95.13.971","article-title":"Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease","volume":"95","author":"van Leeuwen","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.2005.06.225","article-title":"Malignant breast tumors after radiotherapy for a first cancer during childhood","volume":"23","author":"Guibout","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib45","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/jnci\/dji290","article-title":"Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib46","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1210\/jc.85.9.3227","article-title":"Abnormalities of the thyroid in survivors of Hodgkin's disease: Data from the Childhood Cancer Survivor Study","volume":"85","author":"Sklar","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semradonc.2009.09.002_bib47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1200\/JCO.2000.18.3.487","article-title":"Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood","volume":"18","author":"van Leeuwen","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib48","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/S0140-6736(05)66695-0","article-title":"Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): A nested case-control study","volume":"365","author":"Sigurdson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2009.09.002_bib49","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1002\/cncr.11362","article-title":"Thyroid neoplasms after therapeutic radiation for malignancies during childhood or adolescence","volume":"97","author":"Acharya","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib50","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1096-911X(199808)31:2<91::AID-MPO8>3.0.CO;2-U","article-title":"Secondary thyroid carcinoma after treatment for childhood cancer","volume":"31","author":"Black","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib51","first-page":"2885","article-title":"Therapeutic radiation at a young age is linked to secondary thyroid cancer","volume":"51","author":"Tucker","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.semradonc.2009.09.002_bib52","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1210\/jc.77.2.362","article-title":"Dose-response relationships for radiation-induced thyroid cancer and thyroid nodules: Evidence for the prolonged effects of radiation on the thyroid","volume":"77","author":"Schneider","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semradonc.2009.09.002_bib53","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1667\/RR3605.1","article-title":"Thyroid cancer in childhood cancer survivors: A detailed evaluation of radiation dose response and its modifiers","volume":"166","author":"Ronckers","year":"2006","journal-title":"Radiat Res"},{"key":"10.1016\/j.semradonc.2009.09.002_bib54","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1200\/JCO.2005.02.7235","article-title":"Risk of selected subsequent carcinomas in survivors of childhood cancer: A report from the Childhood Cancer Survivor Study","volume":"24","author":"Bassal","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib55","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa064601","article-title":"Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease","volume":"357","author":"Ferme","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2009.09.002_bib56","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2002.08.021","article-title":"Long-term survival and competing causes of death in patients with early-stage Hodgkin's disease treated at age 50 or younger","volume":"20","author":"Ng","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib57","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin's disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib58","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/0140-6736(93)90880-P","article-title":"Sex differences in risk of second malignant tumours after Hodgkin's disease in childhood","volume":"341","author":"Tarbell","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2009.09.002_bib59","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","article-title":"Second malignant neoplasms among long-term survivors of Hodgkin's disease: A population-based evaluation over 25 years","volume":"20","author":"Dores","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib60","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1200\/JCO.2006.09.0936","article-title":"Long-term solid cancer risk among 5-year survivors of Hodgkin's lymphoma","volume":"25","author":"Hodgson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib61","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jnci\/94.3.182","article-title":"Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease","volume":"94","author":"Travis","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib62","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1667\/0033-7587(2003)159[0161:LCATFH]2.0.CO;2","article-title":"Lung cancer after treatment for Hodgkin's disease: Focus on radiation effects","volume":"159","author":"Gilbert","year":"2003","journal-title":"Radiat Res"},{"key":"10.1016\/j.semradonc.2009.09.002_bib63","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1200\/JCO.2001.19.6.1610","article-title":"Lung cancer after Hodgkin's disease: A nested case-control study of the relation to treatment","volume":"19","author":"Swerdlow","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib64","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1093\/jnci\/dji278","article-title":"Second cancers among 40,576 testicular cancer patients: Focus on long-term survivors","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib65","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/jnci\/dji185","article-title":"Risk of contralateral testicular cancer: A population-based study of 29,515 U.S. men","volume":"97","author":"Fossa","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib66","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/jnci\/92.14.1165","article-title":"Treatment-associated leukemia following testicular cancer","volume":"92","author":"Travis","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib67","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0140-6736(91)90490-G","article-title":"Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours","volume":"338","author":"Pedersen-Bjergaard","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2009.09.002_bib68","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/(SICI)1097-0215(19991210)83:6<860::AID-IJC32>3.0.CO;2-L","article-title":"Therapy-related malignancies following treatment of germ cell cancer","volume":"83","author":"Kollmannsberger","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib69","doi-asserted-by":"crossref","first-page":"463","DOI":"10.7326\/0003-4819-136-6-200203190-00010","article-title":"Long-term medical care of testicular cancer survivors","volume":"136","author":"Vaughn","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semradonc.2009.09.002_bib70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program","volume":"12","author":"Hayat","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.semradonc.2009.09.002_bib71","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ijrobp.2006.12.011","article-title":"Risk of second malignancies after adjuvant radiotherapy for breast cancer: A large-scale, single-institution review","volume":"68","author":"Kirova","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2009.09.002_bib72","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0360-3016(03)00203-7","article-title":"Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: A population-based study","volume":"56","author":"Gao","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2009.09.002_bib73","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJM199203193261201","article-title":"Cancer in the contralateral breast after radiotherapy for breast cancer","volume":"326","author":"Boice","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2009.09.002_bib74","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ijrobp.2006.07.009","article-title":"Twenty-year incidence and patterns of contralateral breast cancer after breast conservation treatment with radiation","volume":"66","author":"Hill-Kayser","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2009.09.002_bib75","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/bjc.1986.201","article-title":"Risk of contralateral breast cancer in Denmark 1943-80","volume":"54","author":"Storm","year":"1986","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib76","doi-asserted-by":"crossref","first-page":"5561","DOI":"10.1200\/JCO.2007.16.0192","article-title":"Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer","volume":"26","author":"Hooning","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib77","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2009.09.002_bib78","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ijrobp.2008.02.040","article-title":"Dose to the contralateral breast from radiotherapy and risk of second primary breast cancer in the WECARE study","volume":"72","author":"Stovall","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2009.09.002_bib79","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(05)66544-0","article-title":"Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials","volume":"365","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2009.09.002_bib80","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/jnci\/86.7.527","article-title":"Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14","volume":"86","author":"Fisher","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib81","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","article-title":"Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study","volume":"90","author":"Fisher","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib82","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1993.11.3.485","article-title":"High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients","volume":"11","author":"Magriples","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib83","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0140-6736(00)02677-5","article-title":"Risk and prognosis of endometrial cancer after tamoxifen for breast cancer","volume":"356","author":"Bergman","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.semradonc.2009.09.002_bib84","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cncr.22734","article-title":"Outcomes in patients with primary breast cancer and a subsequent diagnosis of endometrial cancer: Comparison of cohorts treated with and without tamoxifen","volume":"110","author":"Saadat","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib85","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10549-007-9509-8","article-title":"Risk of second non-hematological malignancies among 376,825 breast cancer survivors","volume":"106","author":"Brown","year":"2007","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.semradonc.2009.09.002_bib86","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/sj.bjc.6602084","article-title":"Radiation-induced malignancies following radiotherapy for breast cancer","volume":"91","author":"Roychoudhuri","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib87","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1002\/1097-0142(19930515)71:10<3054::AID-CNCR2820711027>3.0.CO;2-N","article-title":"Lung cancer after radiation therapy for breast cancer","volume":"71","author":"Neugut","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib88","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/cncr.11214","article-title":"Lung carcinoma after radiation therapy in women treated with lumpectomy or mastectomy for primary breast carcinoma","volume":"97","author":"Zablotska","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib89","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/cncr.11655","article-title":"The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy","volume":"98","author":"Deutsch","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib90","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.bjc.6604241","article-title":"Second malignancies after breast cancer: The impact of different treatment modalities","volume":"98","author":"Kirova","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib91","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/jnci\/87.1.60","article-title":"Re: Lung cancer risk and radiation dose among women treated for breast cancer","volume":"87","author":"Travis","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semradonc.2009.09.002_bib92","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1002\/1097-0142(19940315)73:6<1615::AID-CNCR2820730612>3.0.CO;2-6","article-title":"Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers","volume":"73","author":"Neugut","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib93","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/cncr.11669","article-title":"Effects of smoking and radiotherapy on lung carcinoma in breast carcinoma survivors","volume":"98","author":"Ford","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib94","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.2007.13.3033","article-title":"Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer","volume":"26","author":"Kaufman","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib95","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/aje\/kwi050","article-title":"Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer","volume":"161","author":"Zablotska","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib96","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/1097-0142(20010701)92:1<172::AID-CNCR1306>3.0.CO;2-K","article-title":"Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma","volume":"92","author":"Huang","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib97","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0959-8049(98)00319-0","article-title":"Soft tissue sarcoma after treatment for breast cancer\u2014a Swedish population-based study","volume":"34","author":"Karlsson","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib98","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/cncr.21223","article-title":"Radiation-induced sarcomas after radiotherapy for breast carcinoma: A large-scale single-institution review","volume":"104","author":"Kirova","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib99","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/sj.bjc.6601138","article-title":"Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment","volume":"89","author":"Rubino","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib100","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1001\/archderm.1952.01530210002001","article-title":"Angiosarcoma in postmastectomy lymphedema (Stewart-Treves syndrome)","volume":"65","author":"Jessner","year":"1952","journal-title":"AMA Arch Derm Syphilol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib101","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1524-4725.2007.33156.x","article-title":"Angiosarcoma developing after conservative treatment for breast carcinoma: Case report with review of the current literature","volume":"33","author":"Esler-Brauer","year":"2007","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.semradonc.2009.09.002_bib102","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/sj.bjc.6603805","article-title":"Angiosarcoma after radiotherapy: A cohort study of 332,163 Finnish cancer patients","volume":"97","author":"Virtanen","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib103","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000079885","article-title":"Radiation-induced angiosarcomas","volume":"209","author":"Simonart","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.semradonc.2009.09.002_bib104","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1056\/NEJM199206253262605","article-title":"Risk of leukemia after chemotherapy and radiation treatment for breast cancer","volume":"326","author":"Curtis","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semradonc.2009.09.002_bib105","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1200\/JCO.2005.05.029","article-title":"Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: Correlation with doses of epirubicin and cyclophosphamide","volume":"23","author":"Praga","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib106","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/annonc\/mdi251","article-title":"Secondary leukemia after epirubicin-based adjuvant chemotherapy in operable breast cancer patients: 16 years experience of the French Adjuvant Study Group","volume":"16","author":"Campone","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib107","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.2003.03.114","article-title":"Acute myeloid leukemia and myelodysplastic syndrome after doxorubicin-cyclophosphamide adjuvant therapy for operable breast cancer: The National Surgical Adjuvant Breast and Bowel Project Experience","volume":"21","author":"Smith","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib108","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000106040","article-title":"Partial breast irradiation: patient selection, guidelines for treatment, and current results","volume":"40","author":"Chen","year":"2007","journal-title":"Front Radiat Ther Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib109","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/cncr.22083","article-title":"Cancer incidence after localized therapy for prostate cancer","volume":"107","author":"Moon","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib110","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ijrobp.2005.11.013","article-title":"Prostatic irradiation is not associated with any measurable increase in the risk of subsequent rectal cancer","volume":"65","author":"Kendal","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2009.09.002_bib111","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.ju.0000163459.57305.a1","article-title":"Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer","volume":"174","author":"Chrouser","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib112","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0167-8140(02)00307-9","article-title":"The risk of second malignancy in men with prostate cancer treated with or without radiation in British Columbia, 1984-2000","volume":"65","author":"Pickles","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib113","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V","article-title":"Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery","volume":"88","author":"Brenner","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.semradonc.2009.09.002_bib114","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00066-007-1631-3","article-title":"Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: A review and future perspectives","volume":"183","author":"Guckenberger","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib115","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ijrobp.2005.03.053","article-title":"The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy","volume":"62","author":"Kry","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.semradonc.2009.09.002_bib116","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2008-06-164863","article-title":"Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century","volume":"113","author":"Pulte","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semradonc.2009.09.002_bib117","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1667\/0033-7587(2002)158[0220:REOBCR]2.0.CO;2","article-title":"Radiation effects on breast cancer risk: A pooled analysis of eight cohorts","volume":"158","author":"Preston","year":"2002","journal-title":"Radiat Res"},{"key":"10.1016\/j.semradonc.2009.09.002_bib118","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1200\/JCO.2008.20.7738","article-title":"Radiation dose and breast cancer risk in the childhood cancer survivor study","volume":"27","author":"Inskip","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semradonc.2009.09.002_bib119","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.2007.13.0880","article-title":"Long-term smoking cessation outcomes among childhood cancer survivors in the Partnership for Health Study","volume":"27","author":"Emmons","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429609000678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053429609000678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T00:59:02Z","timestamp":1590281942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053429609000678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S1053429609000678"],"URL":"https:\/\/doi.org\/10.1016\/j.semradonc.2009.09.002","relation":{},"ISSN":["1053-4296"],"issn-type":[{"value":"1053-4296","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}